Literature DB >> 21647015

Parkinson's: symptoms, treatments and research.

Daiga Heisters1.   

Abstract

Parkinson's is a incurable progressive neurological condition caused by a degeneration of dopamine-producing cells. The most common symptoms of the condition include slowness of movement, tremor and muscle stiffness; other symptoms include sleep difficulties, depression and anxiety. Parkinson's is usually controlled by medication but other treatments and therapies, such as occupational therapy, physiotherapy and speech and language therapy, can also be effective in controlling and managing symptoms. The timing of this medication is key to the successful management of Parkinson's. Delays to initiating medication or missed doses can have serious consequences, and it can take some time for symptoms to stabilize. Research into treatments for Parkinson's and, ultimately, finding a cure for the condition, is ongoing. Parkinson's UK researchers are working on projects to identify the causes of cell death and tests to detect the condition at its earliest possible stage. Current treatments can help to ease the symptoms but none can repair the damage in the brain or slow the progress of the condition; now, Parkinson's UK researchers are working to develop new treatments that can.

Entities:  

Mesh:

Year:  2011        PMID: 21647015     DOI: 10.12968/bjon.2011.20.9.548

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  11 in total

Review 1.  (Neuro)Psychological Interventions for Non-Motor Symptoms in the Treatment of Patients with Parkinson's Disease: a Systematic Umbrella Review.

Authors:  Hanna Kampling; Lisa K Brendel; Oskar Mittag
Journal:  Neuropsychol Rev       Date:  2019-06-05       Impact factor: 7.444

Review 2.  Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.

Authors:  Subhrangshu Guhathakurta; Eugene Bok; Baggio A Evangelista; Yoon-Seong Kim
Journal:  Prog Neurobiol       Date:  2017-04-23       Impact factor: 11.685

Review 3.  Rifampicin and Parkinson's disease.

Authors:  Wei Bi; Lihong Zhu; Xiuna Jing; Yanran Liang; Enxiang Tao
Journal:  Neurol Sci       Date:  2012-07-21       Impact factor: 3.307

4.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

Review 5.  Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Authors:  Erika Guerrero; P Vasudevaraju; Muralidhar L Hegde; G B Britton; K S Rao
Journal:  Mol Neurobiol       Date:  2012-08-26       Impact factor: 5.590

6.  Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.

Authors:  Chuanfeng Lv; Tie Hong; Zhen Yang; Yu Zhang; Lu Wang; Man Dong; Jing Zhao; Jiaye Mu; Yixiao Meng
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-09       Impact factor: 2.629

7.  What web-based information is available for people with Parkinson's disease interested in aquatic physiotherapy? A social listening study.

Authors:  Aan Fleur Terrens; Sze-Ee Soh; Prue Morgan
Journal:  BMC Neurol       Date:  2022-05-05       Impact factor: 2.903

Review 8.  Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress.

Authors:  Fereshteh Ahmadinejad; Simon Geir Møller; Morteza Hashemzadeh-Chaleshtori; Gholamreza Bidkhori; Mohammad-Saeid Jami
Journal:  Antioxidants (Basel)       Date:  2017-07-10

9.  The safety and feasibility of a Halliwick style of aquatic physiotherapy for falls and balance dysfunction in people with Parkinson's Disease: A single blind pilot trial.

Authors:  Aan Fleur Terrens; Sze-Ee Soh; Prue Morgan
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

10.  Analysis of Smartphone Recordings in Time, Frequency, and Cepstral Domains to Classify Parkinson's Disease.

Authors:  Ilias Tougui; Abdelilah Jilbab; Jamal El Mhamdi
Journal:  Healthc Inform Res       Date:  2020-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.